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GENETIC AND NON-GENETIC FORMS OF 
ANEURYSMS OF THE HUMAN ASCENDING AORTA 
SHARE ACTIVATION AND OVEREXPRESSION OF 
SMAD2: PUTATIVE IMPLICATION OF EPIGENETIC 
MECHANISMS
D. GOMEZ 1, G. JONDEAU 1, J.-B. MICHEL 1, R. VRANCKX 1
1 Inserm, Paris, France
Ascending aortic aneurysm (AscAA) development proceeds by 
multifactorial and chronic processes affecting both vascular 
extracellular matrix structure and integrity and smooth muscle cell 
(SMC) survival. These features are associated with all types of AscAA: 
i) genetic forms associated with mutations in FBN1, TGFBR1 or 
TGFBR2 (Marfan syndrome (MFS) and Loeys-Dietz syndrome (LDS)), 
ii) aneurysms associated with bicuspid aortic valve (BAV) or iii) 
degenerative forms. However, the relation between the genotypic 
variability and the unique aortic phenotype remains unexplained. 
The common matrix perturbations suggest similar cell dysfunction 
in both genetic and non-genetic AscAA. In this context, it has been 
recently proposed that TGF-β1 plays a predominant role in AscAA. 
Here we investigate TGF-β1 and its intracellular mediator Smad 
signaling pathway using tissue extracts and cultured SMCs from 
the media of genetic and non-genetic forms of AscAA. We show 
an increased activation of Smad2 (phosphorylated-Smad2) and 
an increased amount of TGF-β1 in AscAA. However, biochemical 
and histological studies demonstrated an enhancement of TGF-β1 
retention within the extracellular matrix but not in its expression 
and activation, and thus highlight independent dysregulation of 
TGF-β1 retention and Smad2 signaling in genetic and non-genetic 
aneurysms. The constitutive Smad2 activation is independent of 
the extracellular TGF-β1 as well as of TGF-β receptor functionality. 
Aneurysms bearing TGFBR2 mutations, which induce loss of function, 
present constitutive Smad2 activation. Moreover, increased Smad2 
expression is observed in tissue extracts but also in cultured SMC 
extracts, where the overexpression is surprisingly maintained during 
several passages, in AscAA. The study of adventitial  broblasts 
shows that Smad2 perturbations are speci c to SMCs from the 
media of aneurysmal aortic wall. A putative regulation of Smad2 
expression by epigenetic mechanisms (histone acetylation and/
or DNA methylation) is tested. Preliminary results show decreased 
Smad2 expression induced by deacetylase and methylase inhibitors 
in aneurysmal SMCs. In contrast, Smad2 expression, in control SMCs, 
is not affected by these treatments. The constitutive and tissue-
speci c activation of Smad2 and its maintained expression suggest 
an implication of epigenetic mechanisms in the development of 
genetic and non-genetic AscAA.
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BETA-ADRENERGIC STIMULATION ACTIVATES 
PROTEIN KINASE C-EPSILON THROUGH EPAC IN 
CARDIOMYOCYTES
N. DUQUESNES 1, M. METRICH 1, L. LI 1, A. LUCAS 1, P. MATEO 1, 
D. FORTIN 1, E. MOREL 1, F. LEZOUALC’H 1, B. CROZATIER 1
1 Inserm U 769, Chatenay-Malabry, France
Protein kinase C (PKC) activation is classically considered as 
independent of the β-adrenergic pathway. However, the cAMP- 
activated exchange factor Epac was recently shown to activate 
phospholipase C. β-A stimulation is thus likely to stimulate PKC. We 
evaluated in cardiomyocytes whether βA stimulation could activate 
PKCε. Rat neonatal cardiomyocytes were subjected to isoproterenol 
stimulation (ISO). Inositol trisphosphate production was increased 
by 50 % by 1 m ISO (p<0.05) and PKCε was translocated to 
particulate fractions (western blot) in the perinuclear area 
(confocal microscopy) in a PKA-independent manner since it 
was not inhibited by an infection with an adenovirus encoding a 
protein kinase A (PKA) inhibitor. Instead, PKCε activation was Epac 
dependent since 8-CPT, an Epac activator, induced the same PKCε 
translocation as ISO and siRNAs of Epac completetly inhibited PKCε 
activation. The same translocation of PKCε in PF induced by βA 
stimulation was found in adult isolated rat hearts perfused by ISO 
with a sarcolemmmal membrane localization. This was associated 
with a phosphorylation of connexin-43 on ser368 that was blocked 
by the PKC inhibitor BIM. In conclusion, these data demonstrate 
a new interconnection between β-adrenergic and PKC pathways 
via Epac in cardiac cells with a potential role in cell-to-cell 
communications.
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CARDIAC REMODELING FOLLOWING CHRONIC 
ACTIVATION OF THE NOTCH SIGNALING PATHWAY
M. NEMIR 1, M. LEPORE 1, S. CRUCHET 1, A. FELLEY 2, 
C. BERTHONNECHE 2, T. PEDRAZZINI 1,2
1 Department of Medicine, University of Lausanne Medical School, 
Lausanne, Switzerland
2 Cardiovascular Assessment Facility, University of Lausanne 
Medical School, Lausanne, Switzerland
The Notch signaling pathway is a communication system between 
adjacent cells, mediated by transmembrane receptors (Notch1-4) 
and ligands (Jagged1 and 2, Delta-like1, 3, and 4). Notch is essential 
for the development and homeostasis of several self-renewing 
organ systems. Notch is also essential in the developing heart, 
and mutations in Notch genes cause cardiac malformations and 
congenital heart disease. Recently, using loss-of-function studies, we 
showed that the Notch1 receptor controlled the response to injury in 
the adult heart by limiting myocyte hypertrophy, enhancing myocyte 
survival, promoting precursor proliferation, controlling cardiogenic 
differentiation, and reducing interstitial  brosis. In addition, our 
data suggested that upregulation of Jagged1 expression constituted 
a primary response in the stressed myocardium, suggesting that this 
ligand mediated Notch signaling in the postnatal heart. Therefore, 
to analyze the effects of a chronic Jagged1-induced Notch activation 
on the cardiac response to stress, we generated transgenic mice 
overexpressing Jagged1 in cardiomyocytes using the α-myosin 
heavy chain gene promoter (TGMHCJ1 mice). These mice expressed 
100-500 fold Jagged1 mRNA relative to wild-type (WT) controls. 
The overexpression of Jagged1 on the surface of cardiomyocytes 
was con rmed by Western blotting and immuno uorescence 
staining. Consequently, the percentage of cardiac cells with an 
activated Notch pathway was higher in TGMHCJ1 mice than in 
WT animals. The expression of the Notch target genes Hes1 and 
Hey2 was also activated. Echocardiographic analysis under basal 
conditions revealed an enlargement of the right ventricle (RV) with 
a diminished left ventricle (LV) mass and chamber size in adults. 
TGMHCJ1 mice displayed increased juvenile mortality. The severity 
of the phenotype was dependent on the level of Jagged1 expression. 
Immuno uorescence analysis revealed myocyte hypertrophy and 
disarray in the RV of TGMHCJ1 mice whereas, myocytes in the LV were 
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not affected. Moreover, when subjected to transaortic constriction 
(TAC), TGMHCJ1 mice demonstrated an impaired LV hypertrophic 
response to pressure overload and reduced cardiac  brosis. These 
results indicate that chronic activation of Notch affects differently 
left and right ventricle integrity under physiological and pathological 
conditions.
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VASCULAR SMOOTH MUSCLE MODULATES 
ENDOTHELIAL CONTROL OF VASOREACTIVITY VIA 
ROS PRODUCTION THROUGH MYOENDOTHELIAL 
COMMUNICATIONS
M. BILLAUD 1, R. MARTHAN 1, J.-P. SAVINEAU 1, C. GUIBERT 1
1 Université de Bordeaux, Laboratoire de Physiologie Cellulaire 
Respiratoire, Inserm U885, bordeaux, France
Endothelial control of vascular smooth muscle plays a major 
role in the resulting vasoreactivity implicated in physiological or 
pathological circulatory processes. However, a comprehensive 
understanding of endothelial (EC) / smooth muscle cells (SMC) 
crosstalk is far from complete. Here, we have examined the role 
of gap junctions in this crosstalk and we demonstrate an active 
contribution of SMC to endothelial control of vasomotor tone.
In small intrapulmonary arteries, quantitative RT-PCR, Western 
Blot analyses revealed the presence of 3 connexins (Cx): 37, 40 and 
43. Immuno uorescence labelling showed the presence of Cx 37, 
40 and 43 in EC and the presence of Cx 37 and 40 in SMC. Functional 
experiments showed that the peptides homologous to the gap 26 
and 27 domains of the extracellular loops of Cx 43 (43Gap 26) or 
Cx 37 and 43 (37-43Gap 27) respectively, (1) interrupt intercellular 
communications in a speci c manner, (2) attenuate the calcium 
and contractile responses to serotonin (5-HT) simultaneously 
recorded in pulmonary arteries and (3) abolish the diffusion in SMC 
of carboxy uorescein-AM loaded in EC. Similarly, contractile and 
calcium responses to 5-HT were decreased by superoxide dismutase 
and catalase which, catabolize superoxide anion (O2•-) and H2O2, 
respectively. Both Cx- and reactive oxygen species (ROS)-mediated 
effects on the responses to 5-HT were reversed by (1) L-NAME, 
a NO synthase inhibitor, or (2) endothelium removal with CHAPS. 
Electron paramagnetic resonance directly demonstrated that 5-HT-
induced ROS production, and more speci cally O2•-, originated 
from the SMC. Finally, 5-HT decreased basal cyclic GMP content 
in isolated intact arteries, whereas a cocktail of 5-HT, superoxide 
dismutase and catalase increased basal cyclic GMP content.
Altogether, the  ndings suggest that 5-HT produces O2•- in the 
smooth muscle and NO in the endothelium. O2•- passes through the 
myoendothelial junctions to decrease endothelial NO production 
and thus strengthen pulmonary vasoreactivity. This is the  rst time 
that we demonstrate a control of the endothelial NO function by the 
smooth muscle is demonstrated. Since ROS is often overproduced in 
many cardiovascular diseases, such process could also be of great 
importance in pathological conditions.
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EFFETS DES CONTRAINTES MÉCANIQUES SUR 
L’INTÉGRINE ALPHA V BETA 3 DES CELLULES 
MUSCULAIRES LISSES VASCULAIRES
X. MAO 1, R. SAID 1, H. LOUIS 1, Z. LI 1, V. REGNAULT 1, 
P. LACOLLEY 1
1 Inserm U961 et Université Henri Poincaré, Vandœuvre-lès-Nancy, 
France
L’expression de l’intégrine αvβ3 pourrait jouer un rôle dans le tonus 
vasomoteur et le remodelage de la paroi vasculaire. Nous avons 
examiné l’effet des contraintes mécaniques sur l’expression de cette 
intégrine et l’apoptose des cellules musculaires lisses vasculaires 
(CML) en relation avec leur capacité à générer la thrombine. Nous 
avons utilisé un modèle de cultures primaires de CML d’aorte de rat 
Wistar soumis à des contraintes pulsatiles avec un appareil de type 
Flexercell (1 Hz, 10 % d’élongation, dans un milieu à 0.5 % de sérum 
de veau fœtal). L’ARNm de la sous-unité αV est augmenté après 1 h 
d’exposition aux contraintes mécaniques et celui de la sous-unité β3 
après 3 h. Cela s’accompagne dés la 30e min d’une augmentation 
de l’expression des marqueurs de différenciation (chaîne lourde de 
la myosine, sm-actine et smootheline) d’un facteur 2. Au niveau 
protéique, l’augmentation de l’intégrine αvβ3 et des marqueurs de 
différenciation est observée à partir de 24 h, et la phosphorylation des 
molécules p38, FAK et ERK à 48 h. Une réponse apoptotique, quanti ée 
par l’expression de phospholipides procoagulants à la surface des CML, 
survient dès 5 min. La concentration en thrombine active mesurée 
par thrombinographie in vitro est augmentée d’un facteur 1.7 par 
les contraintes mécaniques. L’intégrine αvβ3 étant le récepteur de 
la prothrombine au niveau des CML, nous avons étudié l’effet d’un 
anticorps fonctionnel anti-αVβ3. A l’état basal, la concentration 
maximale en thrombine par les CML est diminuée en présence de cet 
anticorps. En conclusion, l’augmentation d’expression de l’intégrine 
αvβ3 et de l’exposition de phospholipides anioniques à la surface 
externe des membranes en réponse aux contraintes mécaniques 
pourrait expliquer l’augmentation de thrombine par les CML.
J010
THROMBIN AND THROMBOMODULIN ACTIVATE 
THE EPIDERMAL GROWTH FACTOR RECEPTOR 
SIGNALLING TO MODULATE MONOCYTE ADHERENCE 
TO ENDOTHELIUM
P. CHIENG-YANE 1, F. RENDU 1, B. LE BONNIEC 2, M. DAVID-DUFILHO 1
1 UMRS 956 Université Pierre et Marie Curie-Inserm, Paris, France
2 UMRS 765 Université René Descartes-Inserm, Paris, France
Thrombomodulin is a transmembrane proteoglycan with an 
ectodomain released in blood. Known as the thrombin-cofactor 
to inhibit coagulation, thrombomodulin has also a key role in 
 brinolysis, development, cellular proliferation and in ammation. 
We previously demonstrated that the endothelial thrombomodulin 
has a speci c signalling pathway and mediates Epidermal Growth 
Factor Receptor (EGFR) transactivation. Here, we explored the 
hypothesis that soluble thrombomodulin, which contains the 
N-terminal lectin C-like region and 6 EGF -like domains mediates 
the EGFR transactivation by thrombin.
Human endothelial cells were incubated with either thrombin to 
activate both thrombomodulin and PAR-1, or a mutant thrombin 
that is unable to activate PAR-1, or a recombinant soluble 
thrombomodulin. The EGFR tyrosine kinase was inhibited by 
